RNA Outsourcing Resources

1. 5 Key Considerations For Companies Outsourcing Process Development 6/9/2025

   Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

2. What Is The Role Of CROs In Drug Development? 5/13/2025

   CROs are not just facilitators but strategic innovators essential for delivering new therapies to patients efficiently and safely.

3. Eliminating Antibiotic Resistance Gene Transfer Risks In CGTs 8/14/2023

   Learn about the drawbacks of antibiotic resistance that can cause side effects in patients and how an antibiotic-free approach can ease the burden of regulatory compliance and accelerate development.

4. Improving Pre-Clinical Study Efficiency With mRNA-LNP Technology 11/20/2024

   Uncover how Repair Biotechnologies, in collaboration with Vernal Biosciences, helped to pave the way for the next generation of breakthrough treatments for cholesterol and aging-related diseases.

5. 5 Outdated Practices Holding Back Modern Bioanalysis 10/20/2025

   Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

6. How To Build Effective Clinical Trial Oversight And Leadership 7/14/2025

   In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.

7. Benefits Of Isolator Technology In Fill-Finish 12/10/2025

   Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

8. The Current And Future Value Of mRNA Vaccines And Therapeutics 2/4/2026

   Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how our expertise is advancing mRNA drug development.

9. Enabling CDMOs To Focus On Core Priorities 4/26/2024

   Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.

10. Getting CMC Right For Emerging Technologies 12/20/2023

    Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.